Ozge Sarac

Ozge Sarac

Auto-generated profile, based on publicly available information

Ozge Sarac

Ankara Atatürk Training and Research Hospital, 2nd Ophthalmology Department, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2010 in Current Eye Research
Verified
Journal Article
Closed access
PDF file
CGCanan Gürdal
Canan Gürdal
ÖSÖzge Saraç
Özge Saraç
IGİpEk Genç
İpEk Genç
HKHale Kırımlıoğlu
Hale Kırımlıoğlu
TTTamer Takmaz
Tamer Takmaz
ICİzZet Can
İzZet Can
Purpose: To evaluate the tear function tests and the ocular surface damage in Graves’ disease (GD) patients either with or without thyroid associated orbitopathy (TAO). Methods: Forty-two eyes of 21 randomly selected patients with GD, and 30 eyes of 15 healthy subjects were included in this prospective study. The presence of TAO was evaluated clinically. The palpebral fissure height, degree of proptosis, ocular surface disease index (OSDI), Schirmer tear test, tear break-up time (TBUT), and conjunctival impression cytology were assessed. The results were first compared between the patient and the control groups. Results were then compared between the patients with TAO (group I) and without TAO (group II). Results: The mean OSDI score in the patient group was 44.79 ± 11.83 and it was 21.17 ± 9.89 in the control group (p = 0.001). The mean Schirmer tear test score was 14.4 ± 8.32 mm and 24.9 ± 3.57 mm in the patient and control group, respectively (p = 0.001). The mean TBUT in the patient group was 7.1 sec. In the control group it was significantly increased to 10 sec (p = 0.003). The mean proptosis and interpalpebral distance did not show any difference between the GD patients and controls (p > 0.05). The patients with GD showed significant ocular surface damage in which 75.71% had grade 2–3 squamous metaplasia in temporal interpalpebral conjunctiva. Twenty-four (57%) eyes composed group I. There were no differences in the mean OSDI score, Schirmer tear test score, TBUT, and the amount of ocular surface damage between group I and group II (p > 0.05). Conclusions: Dry eye findings and the ocular surface damage in GD were most likely associated with the ocular surface inflammation. Before the development of the classic findings of TAO, ocular surface inflammation can be the only presenting clinical sign in GD.

1 August 2005 in Current Opinion in Ophthalmology
Verified
Journal Article
Closed access
OIOzge Ilhan-Sarac
Ozge Ilhan-Sarac
EAEsen Karamursel Akpek
Esen Karamursel Akpek
Diseases affecting the cornea are a major cause of blindness worldwide, second only to cataract in overall importance, with an estimated 10 to 15 million affected people. Although keratoplasty is by far the most successful transplantation surgery, the outcomes in high-risk adult patients, including those with ocular surface diseases and multiple graft rejections, and in pediatric patients with congenital corneal opacities are disappointing. Regrettably, no significant clinical developments have been achieved in the field of corneal transplantation since the introduction of steroids for graft rejection. Furthermore, obtaining donor corneal tissues and eye banking, particularly in the developing countries where corneal blindness is most prevalent, are problematic. Although the postoperative complications may be severe and limit the use of currently available devices, keratoprosthesis - artificial corneal implantation - has a role in the management of corneal blindness in carefully selected patients with complex ocular diseases who are at high risk for graft failure. This article reviews the recent ophthalmic literature published on the current concepts and techniques of keratoprosthesis surgery.

1 September 2012 in Journal of Neuro-Ophthalmology
Verified
Journal Article
Closed access
OSOzge Sarac
Ozge Sarac
YTYelda Y. Tasci
Yelda Y. Tasci
CGCanan Gurdal
Canan Gurdal
ICIzzet Can
Izzet Can
Background: To assess the efficacy of quantitative analysis of the optic nerve head and peripapillary retinal nerve fiber layer (RNFL) with the spectral-domain optical coherence tomography (SD-OCT) in differentiating optic disc edema (ODE) from optic nerve head drusen (ONHD). Methods: Prospective clinical study. Twenty-five eyes of 25 ODE patients (group 1), 25 eyes of 25 ONHD patients (group 2), and 25 eyes of 25 healthy subjects were included. The thickness of the peripapillary RNFL, the thickness of the subretinal hyporeflective space (SHYPS), the area of the SHYPS, the horizontal length of the optic nerve head, and the angle between the temporal RNFL and the optic nerve head (α-angle) were evaluated with SD-OCT. Results: The mean RNFL thickness was significantly greater in group 1 when compared with group 2 and control group (P < 0.001). The receiver operating characteristic curve areas for temporal and nasal RNFL thicknesses in differentiating group 1 and group 2 were 0.819 and 0.851, respectively (for temporal RNFL thickness >101.5 μm: sensitivity 92%, specificity 65%; for nasal RNFL thickness >74.5 μm: sensitivity 92%, specificity 47%). The mean SHYPS thickness, SHYPS area, and degree of the α-angle were greater in group 1 when compared with group 2 (P < 0.05). For the SHYPS thickness >464 μm: 85% sensitivity and 60% specificity; for the SHYPS area >811 μm2: 85% sensitivity and 89% specificity; and for the α-angle >141°: 77% sensitivity and 95% specificity were obtained. Conclusion: The quantitative analysis of the optic nerve head and peripapillary RNFL with SD-OCT can provide useful data in differentiating ODE from ONHD.

26 August 2010 in Current Eye Research
Verified
Journal Article
Closed access
PDF file
CGCanan Gürdal
Canan Gürdal
IGİpek Genç
İpek Genç
ÖSÖzge Saraç
Özge Saraç
IGİpek Gönül
İpek Gönül
TTTamer Takmaz
Tamer Takmaz
ICİzzet Can
İzzet Can
Objectives: To evaluate the effects of topical cyclosporine A (CsA) 0.05% (Restasis) on the signs and symptoms of dry eye, on apoptosis, and on MMP-9 expression in conjunctiva epithelial cells in thyroid orbitopathy (TO)-related dry eye patients. Methods: Prospective, clinical study. Twenty-four eyes of 12 consecutive TO patients with dry eye findings instilled CsA twice daily for 2 months. Ocular surface disease index, Schirmer tear test, tear breakup time (TBUT), conjunctival apoptosis index, and conjunctival MMP-9 expression were evaluated before and after 2 months treatment. Conjunctival biopsies were harvested from all eyes at baseline and after 2 months treatment. Apoptosis was detected by the terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling (TUNEL) assay. MMP-9 expression was determined by immunohistochemistry. Results: After 2 months of topical CsA treatment, the mean OSDI score was significantly decreased from 58.08 ± 6.28 to 36.41 ± 11.75 (P = 0.001). At baseline, the mean Schirmer tear test score was 8.92 ± 5.52 mm. It was increased to 11.25 ± 4.71 mm after treatment (P > 0.05). The mean TBUT increased significantly from 3.92 ± 2.18 sec to 9.16 ± 3.34 sec (P = 0.001). The mean percentage of apoptosis index at baseline was 72.10 ± 35.82%. This was significantly decreased to 53.29 ± 34.46% after treatment (P = 0.008). The mean percentage of MMP-9 expression of the conjunctival epithelial cells was significantly decreased from 48.12 ± 28.58% to 26.66 ± 25.13% following treatment (P = 0.005). Conclusions: Topical CsA treatment appears to improve the signs and symptoms of dry eye and inhibits apoptosis and MMP-9 expression in conjunctival epithelial cells in TO-related dry eye patients after 2 months of treatment.

1 October 2018 in Contact Lens and Anterior Eye
Verified
Journal Article
Closed access
OSOzge Sarac
Ozge Sarac
MCMehtap Caglayan
Mehtap Caglayan
BUBetul Seher Uysal
Betul Seher Uysal
AUAyse Guzin Taslipinar Uzel
Ayse Guzin Taslipinar Uzel
BTBurak Tanriverdi
Burak Tanriverdi
NCNurullah Cagil
Nurullah Cagil

1 December 2016 in Cornea
Verified
Journal Article
Closed access
OSOzge Sarac
Ozge Sarac
MCMehtap Caglayan
Mehtap Caglayan
HCHasan Basri Cakmak
Hasan Basri Cakmak
NCNurullah Cagil
Nurullah Cagil
To assess the preoperative patient characteristics that may predict outcomes of keratoconus 2 years after corneal collagen cross-linking (CXL) in pediatric patients with keratoconus. This retrospective study included 72 eyes of 52 consecutive patients with keratoconus under the age of 18 with 2-year follow-up after CXL. Subgroup analysis and cutoff values were determined as per age (<14 and ≥14 years), sex, baseline uncorrected and corrected distance visual acuities (UCVA, CDVA; <0.8 and ≥0.8 logMAR), topographic cone location (central and paracentral), maximum keratometry (K-max, <54 and ≥54 diopters), and corneal thickness at the thinnest point (thCT) (<450 and ≥450 μm) to evaluate the associations between preoperative patient characteristics and outcomes of CXL treatment in terms of K-max. Postoperative progression in K-max was defined as steepening of 1.0 diopter or more. Average age of patients was 14.8 ± 2.2 (9–17) years. After 2 years, the mean UCVA significantly improved and the mean thCT significantly decreased in all patients (P = 0.023, P < 0.001, respectively). The K-max in patients with paracentral cones and/or with thCT less than 450 μm were more likely to progress (cone location: P = 0.023, odds ratio = 3.21, 95% confidence interval, 1.17–8.72; thCT: P = 0.008, odds ratio = 4.54, 95% confidence interval, 1.46–14.14). Age, sex, baseline UCVA, CDVA, and K-max did not present any significant effect on progression of CXL after treatment (P > 0.05 for all variables). In pediatric patients with keratoconus, cone location and the baseline thinnest corneal thickness seem to affect the success rate of CXL treatment after 2-year follow-up.